Retrospective Review of the Efficacy of Lumbar Radiofrequency Ablation for Lumbar Facet Arthropathy: The Influence of Gender and Obesity.

BACKGROUND: Lumbar facet arthropathy is one of the leading causes of back pain. Lumbar radiofrequency lesioning is a therapy for lumbar facet arthropathy that uses heat to ablate the transmission of nerve signals from the medial branches of the spinal nerves associated with the corresponding painful lumbar joints. OBJECTIVES: The present investigation evaluated the outcomes of patients undergoing lumbar radiofrequency ablation at an academic pain program with a special focus on the influence of gender and obesity. STUDY DESIGN: Retrospective chart review. SETTING: Academic tertiary care center. METHODS: We reviewed the charts of 232 patients for age, body mass index, gender, other procedures, and complications, in addition to the primary outcome measurements of Visual Analog Scale pain scores, pain relief percentages, pain relief duration, and functional status improvement per patient report. Associations with outcomes were evaluated with correlations, t tests/analysis of variance, and c2 test. Influences on a change in Visual Analog Scale pain scores before and after treatment were assessed with linear regression. RESULTS: Patients had an average pain reduction of 76.6% (SD = 24.5) from the initial treatment and an average of 30.7 weeks (SD = 21.2) of pain relief from the initial treatment. A total of 83% of the patients reported an improvement in functional status from the initial treatment. Women (mean = 79.8%, SD = 21.4) had a slightly higher pain relief percentage than men (mean = 71.6%, SD = 28.1; P = 0.046). A higher body mass index was associated with less improvement in Visual Analog Scale maximum pain scores from before and after the procedure (b = 0.04; SE = 0.02; P = 0.042). LIMITATIONS: Our study is not a randomized controlled trial; however, based on the number of patients reviewed, our data provide important information regarding lumbar radiofrequency ablations. CONCLUSIONS: This study highlights significant effectiveness for patients undergoing lumbar radiofrequency ablations for lumbar facet joint pain. A variation in effectiveness appears to be influenced by gender and obesity, and therefore additional studies are warranted to further investigate these differences.

Endoscopic Spinal Decompression: A Retrospective Review of Pain Outcomes at an Academic Medical Center.

INTRODUCTION:  Spinal stenosis is a chronic, debilitating condition that is expected to affect an increasing number of people as the population ages. Symptomatic spinal stenosis, like other spine pathologies, including disc herniation and degenerative disc disease, traditionally required an open decompressive surgical approach if more conservative approaches failed. An emerging alternative has been developed to address the needs of this population of patients in the form of endoscopic spine surgery (ESS). Advantages of ESS include minimal tissue trauma, decreased risk of damage to the neurovascular structures, minimal epidural fibrosis/scarring, reduced hospital stay, early functional recovery, and improved cosmetic outcomes. The purpose of this study was to review the outcomes of patients undergoing transforaminal endoscopic spinal decompression at an academic pain program. METHODS: We conducted a retrospective review of electronic medical records with approval from the University of Florida Institutional Review Board (IRB #202001529). Twenty patients underwent successful transforaminal endoscopic lumbar spinal decompression surgery at UF Health Pain Medicine from July 1, 2019, to June 1, 2020. The majority of cases were performed at L4-5 (n = 14), followed by an equal number (n = 3) of cases at L3-4 and L5-S1. Preoperative and postoperative visual analog scale (VAS) pain scores from patients' pain clinic appointments were obtained from the electronic health records system to assess the intervention as a pain relief strategy. RESULTS:  Patients had an average pain reduction of 82% (SD = 31%), resulting in an average postoperative pain score of 1.8 (SD = 2.8) on a 10-point VAS. CONCLUSION:  This study highlights the benefits of endoscopic spine surgery for patients, including pain reduction and reduced scarring.

A Case Report on Spinal Cord Stimulation in an Atrophic Spinal Cord: What Exactly Are We Stimulating?

INTRODUCTION: We present a patient with paraplegia secondary to anterior spinal cord infarct below T6, with subsequent development of chronic low-back and bilateral lower-extremity neuropathic pain with an atrophic cord. In this patient with reduced spinal cord mass and modified neuroanatomy, spinal cord stimulation was surprisingly very effective. OBJECTIVES: The primary objective of this report is to describe a case in which a patient benefited from spinal cord stimulator therapy in a way that is not explained by the traditionally accepted mechanism of action. METHODS: A spinal cord stimulator was implanted with two 16-contact leads placed in series starting at the top of T6. RESULTS: He reported complete resolution of low-back pain and about 50% resolution of bilateral lower-extremity pain. CONCLUSION: Traditionally accepted mechanisms of action of dorsal column stimulation and suppression of wide-dynamic-range neurons are unlikely to explain the relief obtained in our patient with an atrophic spinal cord. No single consensus has been reached on the primary mechanism through which spinal cord stimulation renders its therapeutic effects. Spinal cord stimulator therapy is promising, and the future direction of its study is discussed.

Prognostic Significance and Functional Role of CEP57 in Prostate Cancer.

We have recently shown that centrosomal protein 57 (CEP57) is overexpressed in a subset of human prostate cancers. CEP57 is involved in intracellular transport processes, and its overexpression causes mitotic defects as well as abnormal microtubule nucleation and bundling. In the present study, we further characterized the prognostic and functional role of CEP57 in prostate cancer. Unexpectedly, we found that high CEP57 expression is an independent prognostic factor for a more favorable biochemical recurrence-free survival in two large patient cohorts. To reconcile this finding with the ability of CEP57 to cause cell division errors and thus potentially promote malignant progression, we hypothesized that alterations of microtubule-associated transport processes, in particular nuclear translocation of the androgen receptor (AR), may play a role in our finding. However, CEP57 overexpression and microtubule bundling had, surprisingly, no effect on the nuclear translocation of the AR. Instead, we found a significant increase of cells with disarranged microtubules and a cellular morphology suggestive of a cytokinesis defect. Because mitotic dysfunction leads to a reduced daughter cell formation, it can explain the survival benefit of patients with increased CEP57 expression. In contrast, we show that a reduced expression of CEP57 is associated with malignant growth and metastasis. Taken together, our findings underscore that high CEP57 expression is associated with mitotic impairment and less aggressive tumor behavior. Because the CEP57-induced microtubule stabilization had no detectable effect on AR nuclear translocation, our results furthermore suggest that microtubule-targeting therapeutics used in advanced prostate cancer such as docetaxel may have modes of action that are at least in part independent of AR transport inhibition.